Charles Albright, Chief Scientific Officer at Editas Medicine, Inc. (EDIT), sold 622 shares at $26.95 ($17K) on 2020-02-07, disclosed to the SEC on 2020-02-10.
Open-market sale of $17k EDIT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EDIT | SELL | 2020-12-08 | $1.6M | — | Filing → |
| EDIT | SELL | 2020-11-10 | $7K | — | Filing → |
| EDIT | SELL | 2020-10-16 | $94K | — | Filing → |